{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:38:22Z","timestamp":1790069902460,"version":"4.0.1"},"reference-count":108,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T00:00:00Z","timestamp":1546992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>Schistosomiasis is an acute and chronic disease that affects over 200 million people worldwide, and with over 700 million people estimated to be at risk of contracting this disease, it is a pressing issue in global health. However, research and development (R&amp;D) to develop new approaches to preventing, diagnosing, and treating schistosomiasis has been relatively limited. Praziquantel, a drug developed in the 1970s, is the only agent used in schistosomiasis mass drug administration (MDA) campaigns, indicating a critical need for a diversified therapeutic pipeline. Further, gaps in the vaccine and diagnostic pipelines demonstrate a need for early-stage innovation in all areas of schistosomiasis product R&amp;D. As a platform for public-private partnerships (PPPs), the WIPO Re:Search consortium engages the private sector in early-stage R&amp;D for neglected diseases by forging mutually beneficial collaborations and facilitating the sharing of intellectual property (IP) assets between the for-profit and academic\/non-profit sectors. The Consortium connects people, resources, and ideas to fill gaps in neglected disease product development pipelines by leveraging the strengths of these two sectors. Using WIPO Re:Search as an example, this article highlights the opportunities for the PPP model to play a key role in the elimination of schistosomiasis.<\/jats:p>","DOI":"10.3390\/tropicalmed4010011","type":"journal-article","created":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T03:22:31Z","timestamp":1547090551000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["WIPO Re:Search\u2014A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis"],"prefix":"10.3390","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7481-1306","authenticated-orcid":false,"given":"Callie J.","family":"Weber","sequence":"first","affiliation":[{"name":"BIO Ventures for Global Health, 2101 Fourth Avenue, Suite 1950, Seattle, WA 98121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hargan-Calvopi\u00f1a","sequence":"additional","affiliation":[{"name":"BIO Ventures for Global Health, 2101 Fourth Avenue, Suite 1950, Seattle, WA 98121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy M.","family":"Graef","sequence":"additional","affiliation":[{"name":"BIO Ventures for Global Health, 2101 Fourth Avenue, Suite 1950, Seattle, WA 98121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1955-8608","authenticated-orcid":false,"given":"Cathyryne K.","family":"Manner","sequence":"additional","affiliation":[{"name":"BIO Ventures for Global Health, 2101 Fourth Avenue, Suite 1950, Seattle, WA 98121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Dent","sequence":"additional","affiliation":[{"name":"BIO Ventures for Global Health, 2101 Fourth Avenue, Suite 1950, Seattle, WA 98121, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2018). Schistosomiasis and soil-transmitted helminthiases: Number of people treated in 2017. WHO Wkly. Epidemiological Rec., 93, 681\u2013692."},{"key":"ref_2","first-page":"28","article-title":"Schistosomiasis: Health Effects on Women","volume":"3","author":"Nour","year":"2010","journal-title":"Rev. Obsterics Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4269\/ajtmh.1974.23.902","article-title":"Schistosomiasis mansoni in Yemeni in California: Duration of infection, presence of disease, therapeutic management","volume":"23","author":"Warren","year":"1974","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"ref_5","first-page":"643","article-title":"Developmental bilharziasis caused by Schistosoma mansoni discovered 37 years after infestation","volume":"78","author":"Chabasse","year":"1985","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(06)69440-3","article-title":"Human Schistosomiasis","volume":"368","author":"Gryseels","year":"2006","journal-title":"Lancet"},{"key":"ref_7","unstructured":"World Health Organization (2013). Schistosomiasis: Progress Report 2001\u20132011, Strategic Plan 2012\u20132020, World Health Organization."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","article-title":"Schistosomiasis and water resources development: Systematic review, meta-analysis, and estimates of people at risk","volume":"6","author":"Steinmann","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jare.2012.12.001","article-title":"Hepatic and intestinal schistosomiasis: Review","volume":"4","author":"Elbaz","year":"2013","journal-title":"J. Adv. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1750-9378-8-19","article-title":"Schistosomiasis and urinary bladder cancer in North Western Tanzania: A retrospective review of 185 patients","volume":"8","author":"Rambau","year":"2013","journal-title":"Infect. Agents Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ray, D., Nelson, T.A., Fu, C.L., Patel, S., Gong, D.N., Odegaard, J.I., and Hsieh, M.H. (2012). Transcriptional profiling of the bladder in urogenital schistosomiasis reveals pathways of inflammatory fibrosis and urothelial compromise. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001912"},{"key":"ref_12","unstructured":"(2018, September 17). Center For Disease Control and Prevention\/Schistosomiasis FAQ, Available online: https:\/\/www.cdc.gov\/parasites\/schistosomiasis\/gen_info\/faqs.html."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mon\u00e9, H., Minguez, S., Ibikounl\u00e9, M., Allienne, J.F., Massougbodji, A., and Mouahid, G. (2012). Natural Interactions between S. haematobium and S. guineensis in the Republic of Benin. Sci. World J., 2012.","DOI":"10.1100\/2012\/793420"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/1742395307084407","article-title":"The unacknowledged impact of chronic schistosomiasis","volume":"4","author":"King","year":"2008","journal-title":"Chronic Illn"},{"key":"ref_15","unstructured":"GBD 2017 DALYs and HALE Collaborators (2018). Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancelet, 392, 859\u2013922."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2009.11.012","article-title":"Parasites and poverty: The case of schistosomiasis","volume":"113","author":"King","year":"2010","journal-title":"Acta Trop."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/00034983.1993.11812810","article-title":"The physical fitness and work performance of agricultural workers infected with Schistosoma mansoni in Zimbabwe","volume":"87","author":"Ndamba","year":"1993","journal-title":"Anal. Trop. Med. Parasitol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4269\/ajtmh.2005.72.527","article-title":"Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines","volume":"72","author":"Friedman","year":"2005","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/IAI.01060-13","article-title":"Maternal infection with Schistosoma japonicum induces a profibrotic response in neonates","volume":"82","author":"McDonald","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1128\/IAI.01072-10","article-title":"Maternal Schistosomiasis japonica is associated with maternal, placental, and fetal inflammation","volume":"79","author":"Kurtis","year":"2011","journal-title":"Infect. Immun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1016\/j.actatropica.2010.12.009","article-title":"Impact of Schistosoma haematobium infection on urinary tract pathology, nutritional status and anaemia in school-aged children in two different endemic areas of the Niger River Basin, Mali","volume":"120","author":"Sacko","year":"2011","journal-title":"Acta Trop."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pt.2013.02.001","article-title":"Schistosomiasis in African infants and preschool children: Let them now be treated!","volume":"29","author":"Stothard","year":"2013","journal-title":"Trends Parasitol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1128\/CMR.12.1.97","article-title":"Relationship between Schistosomiasis and Bladder Cancer","volume":"12","author":"Mostafa","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bjid.2014.11.004","article-title":"Impact of human schistosomiasis in sub-Saharan Africa","volume":"19","author":"Adenowo","year":"2015","journal-title":"Braz. J. Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/apm.12756","article-title":"Angiogenesis in Schistosoma haematobium-associated urinary bladder cancer","volume":"125","author":"Dematei","year":"2017","journal-title":"APMIS"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0027-5107(94)90248-8","article-title":"Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients","volume":"305","author":"Rosin","year":"1994","journal-title":"Mut. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.trstmh.2005.10.010","article-title":"Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana","volume":"100","author":"Shiff","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_29","unstructured":"International Agency for Research on Cancer (2012). Biological Agents. Volume 100B. A Review of Human Carcinogenesis. IARC Monogr. Evalutation Carcinogenic Risks Hum., 100, 1\u2013441."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.1986.224","article-title":"Reversibility of urinary tract abnormalities due to Schistosoma haematobium infection","volume":"30","author":"Doehring","year":"1986","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e9430","DOI":"10.5812\/ijcm.9430","article-title":"Halting Schistosoma haematobium\u2014Associated bladder cancer","volume":"10","author":"Botelho","year":"2017","journal-title":"Int. J. Cancer Manag."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pt.2011.10.008","article-title":"A Review of Female Genital Schistosomiasis","volume":"28","author":"Kjetland","year":"2012","journal-title":"Trends Parasitol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Santos, J., Gouveia, M.J., Vale, N., Delgado Mde, L., Goncalves, A., da Silva, J.M., Oliveira, C., Xavier, P., Gomes, P., and Santos, L.L. (2014). Urinary Estrogen Metabolites and Self-Reported Infertility in Women Infected With Schistosoma Haematobium. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096774"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pt.2007.02.006","article-title":"Schistosomiasis and pregnancy","volume":"23","author":"Friedman","year":"2007","journal-title":"Trends Parasitol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.aids.0000210614.45212.0a","article-title":"Association between genital schistosomiasis and HIV in rural Zimbabwean women","volume":"20","author":"Kjetland","year":"2006","journal-title":"AIDS"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.4269\/ajtmh.15-0652","article-title":"Association Between Schistosoma haematobium Exposure and Human Immunodeficiency Virus Infection Among Females in Mozambique","volume":"94","author":"Brodish","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1128\/IAI.71.11.6668-6671.2003","article-title":"Increased Density of Human Immunodeficiency Virus Type 1 Coreceptors CCR5 and CXCR4 on the Surfaces of CD4+ T Cells and Monocytes of Patients with Schistosoma mansoni Infection","volume":"71","author":"Secor","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4269\/ajtmh.1970.19.779","article-title":"Schistosomiasis of the male pelvic organs. Severity of infection determined by digestion of tissue and histologic methods in 300 cadavers","volume":"19","author":"Gelfand","year":"1970","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(99)04856-4","article-title":"Community-based study of genital schistosomiasis in men from Madagascar","volume":"355","author":"Leutscher","year":"2000","journal-title":"Lancet"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/429334","article-title":"Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals","volume":"191","author":"Leutscher","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_41","unstructured":"(2019, January 07). Reaching a Billion. Fifth Progress Report on the London Declaration on NTDs. Available online: https:\/\/unitingtocombatntds.org\/reports\/5th-report\/."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1017\/S0031182013000231","article-title":"New approaches for understanding mechanisms of drug resistance in schistosomes","volume":"140","author":"Greenberg","year":"2013","journal-title":"Parasitology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.parint.2013.02.006","article-title":"ABC multidrug transporters in schistosomes and other parasitic flatworms","volume":"62","author":"Greenberg","year":"2013","journal-title":"Parasitol. Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molbiopara.2014.06.002","article-title":"Schistosomiasis control: Praziquantel forever?","volume":"195","author":"Cioli","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cbpa.2007.05.031","article-title":"Chemotherapy of schistosomiasis: Present and future","volume":"11","author":"Caffrey","year":"2007","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_46","unstructured":"(2018, September 14). World Health Organization: Schistosomiasis Strategy. Available online: http:\/\/www.who.int\/schistosomiasis\/strategy\/en\/."},{"key":"ref_47","first-page":"65","article-title":"Prevention and control of schistosomiasis: A current perspective","volume":"2014","author":"Inobaya","year":"2014","journal-title":"Res. Rep. Trop. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pt.2017.10.002","article-title":"To Reduce the Global Burden of Human Schistosomiasis, Use \u2018Old Fashioned\u2019 Snail Control","volume":"34","author":"Sokolow","year":"2018","journal-title":"Trends Parasitol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S1473-3099(16)30535-7","article-title":"A call to strengthen the global strategy against schistosomiasis and soil-transmitted helminthiasis: The time is now","volume":"17","author":"Lo","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0001-706X(03)00033-0","article-title":"Administration of Praziquantel to pregnant and lactating women","volume":"86","author":"Olds","year":"2003","journal-title":"Acta Trop."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s40249-017-0336-9","article-title":"Developing a comprehensive response for treatment of children under 6 years of age with schistosomiasis: Research and development of a pediatric formulation of praziquantel","volume":"6","author":"Klohe","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.4269\/ajtmh.17-0908","article-title":"Impact of Four Years of Annual Mass Drug Administration on Prevalence and Intensity of Schistosomiasis among Primary and High School Children in Western Kenya: A Repeated Cross-Sectional Study","volume":"98","author":"Abudho","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_53","unstructured":"(2019, January 06). Kenya National School-Based Deworming Programme: Year 2 Report (April 2013\u2013March 2014). Available online: https:\/\/ciff.org\/documents\/16\/Kenya_National_SchoolBased_Deworming_Programme_Year2_evaluation.pdf."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40249-017-0280-8","article-title":"Building a global schistosomiasis alliance: An opportunity to join forces to fight inequality and rural poverty","volume":"6","author":"Savioli","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"ref_55","unstructured":"World Health Organization (2017). Crossing the Billion. Lymphatic Filariasis, Onchocerciasis, Schistosomiasis, Soil-Transmitted Helminthiases and Trachoma: Preventive Chemotherapy for Neglected Tropical Diseases, World Health Organization."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijid.2016.09.023","article-title":"A new global strategy for the elimination of schistosomiasis","volume":"54","author":"Ross","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"ref_57","unstructured":"World Health Organization (2017). Schistosomiasis and soil-transmitted helminthiases: Number of people treated in 2016. WHO Wkly. Epidemiological Rec., 92, 749\u2013760."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"675","DOI":"10.4155\/fmc.15.27","article-title":"Schistosomiasis and its treatment","volume":"7","author":"Caffrey","year":"2015","journal-title":"Future Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1017\/S0031182009000493","article-title":"Praziquantel: Its use in control of schistosomiasis in sub-Saharan Africa and current research needs","volume":"136","author":"Doenhoff","year":"2009","journal-title":"Parasitology"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Zwang, J., and Olliaro, P.L. (2014). Clinical efficacy and tolerability of praziquantel for intestinal and urinary schistosomiasis-a meta-analysis of comparative and non-comparative clinical trials. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003286"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1756-3305-4-201","article-title":"Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: A systematic review and meta-analysis","volume":"4","author":"Liu","year":"2011","journal-title":"Parasit Vectors"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Kasinathan, R.S., Sharma, L.K., Cunningham, C., Webb, T.R., and Greenberg, R.M. (2014). Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003265"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13071-016-1958-7","article-title":"Efficacy and safety of praziquantel 40 mg\/kg in preschool-aged and school-aged children: A meta-analysis","volume":"10","author":"Zwang","year":"2017","journal-title":"Parasit Vectors"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/QCO.0b013e328318978f","article-title":"Praziquantel: Mechanisms of action, resistance and new derivatives for schistosomiasis","volume":"21","author":"Doenhoff","year":"2008","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Pinto-Almeida, A., Mendes, T., Armada, A., Belo, S., Carrilho, E., Viveiros, M., and Afonso, A. (2015). The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140147"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"15058","DOI":"10.3390\/molecules190915058","article-title":"New uses for old drugs: The tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China","volume":"19","author":"Liu","year":"2014","journal-title":"Molecules"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1093\/cid\/ciy001","article-title":"Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?","volume":"66","author":"Toor","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.vaccine.2015.12.032","article-title":"Workshop report: Schistosomiasis vaccine clinical development and product characteristics","volume":"34","author":"Mo","year":"2016","journal-title":"Vaccine"},{"key":"ref_69","unstructured":"Policy Cures Research (2018, September 14). Neglected Disease R&D Product Pipeline. Available online: https:\/\/www.pipeline.policycuresresearch.org\/august2017."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Hotez, P.J. (2018). The global fight to develop antipoverty vaccines in the anti-vaccine era. Hum. Vaccin. Immunother., 1\u20134.","DOI":"10.1080\/21645515.2018.1430542"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2015.00218","article-title":"Development of the Brazilian Anti Schistosomiasis Vaccine Based on the Recombinant Fatty Acid Binding Protein Sm14 Plus GLA-SE Adjuvant","volume":"6","author":"Tendler","year":"2015","journal-title":"Front. Immunol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1080\/21645515.2015.1059981","article-title":"Still hope for schistosomiasis vaccine","volume":"11","author":"Ricciardi","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Riveau, G., Deplanque, D., Remoue, F., Schacht, A.M., Vodougnon, H., Capron, M., Thiry, M., Martial, J., Libersa, C., and Capron, A. (2012). Safety and immunogenicity of rSh28GST antigen in humans: Phase 1 randomized clinical study of a vaccine candidate against urinary schistosomiasis. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001704"},{"key":"ref_74","unstructured":"(2018, September 14). Efficacy of Bilhvax in Association With Praziquantel for Prevention of Clinical Recurrences of Schistosoma Haematobium (Bilhvax3), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00870649?term=Bilhvax&rank=2."},{"key":"ref_75","unstructured":"(2018, September 14). Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03041766?term=sm-14&cond=Schistosomiasis&rank=2."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.vaccine.2015.10.027","article-title":"Schistosomiasis vaccine candidate Sm14\/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults","volume":"34","author":"Coler","year":"2016","journal-title":"Vaccine"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1016\/j.vaccine.2016.03.079","article-title":"Advancing a vaccine to prevent human schistosomiasis","volume":"34","author":"Merrifield","year":"2016","journal-title":"Vaccine"},{"key":"ref_78","unstructured":"(2018, September 14). Sabin Vaccine Institute. Available online: https:\/\/www.sabin.org\/programs\/schistosomiasis."},{"key":"ref_79","unstructured":"(2018, September 14). A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2\/Alhydrogel)(R) with or without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed Adults, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03110757?term=Alhydrogel&rank=8."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pathol.2018.01.004","article-title":"Schistosoma egg-induced liver pathology resolution by Sm-p80-based schistosomiasis vaccine in baboons","volume":"50","author":"Le","year":"2018","journal-title":"Pathology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pt.2016.10.010","article-title":"Sm-p80-Based Schistosomiasis Vaccine: Preparation for Human Clinical Trials","volume":"33","author":"Siddiqui","year":"2017","journal-title":"Trends Parasitol."},{"key":"ref_82","unstructured":"Faulx, D., Storey, H.L., Murray, M.A., Cantera, J.L., Hawkins, K.R., Leader, B.T., Gallo, K.L., and de los Santntos, T. (2019, January 08). Available online: https:\/\/www.finddx.org\/wp-content\/uploads\/2016\/03\/PATH-2015_Dx-for-NTDs-Target-Products-Profile-report.pdf."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40249-017-0289-z","article-title":"Selecting accurate post-elimination monitoring tools to prevent reemergence of urogenital schistosomiasis in Morocco: A pilot study","volume":"6","author":"Balahbib","year":"2017","journal-title":"Infect. Dis. Poverty"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.4269\/ajtmh.14-0643","article-title":"Evaluation of point-of-contact circulating cathodic antigen assays for the detection of Schistosoma mansoni infection in low-, moderate-, and high-prevalence schools in western Kenya","volume":"92","author":"Foo","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Lindholz, C.G., Favero, V., Verissimo, C.M., Candido, R.R.F., de Souza, R.P., Dos Santos, R.R., Morassutti, A.L., Bittencourt, H.R., Jones, M.K., and St Pierre, T.G. (2018). Study of diagnostic accuracy of Helmintex, Kato-Katz, and POC-CCA methods for diagnosing intestinal schistosomiasis in Candeal, a low intensity transmission area in northeastern Brazil. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006274"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1017\/S0031182018000240","article-title":"Diagnosis of schistosomiasis mansoni: An evaluation of existing methods and research towards single worm pair detection","volume":"145","author":"Ogongo","year":"2018","journal-title":"Parasitology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1017\/S0031182006000898","article-title":"A new PCR-based approach for the specific amplification of DNA from different Schistosoma species applicable to human urine samples","volume":"133","author":"Sandoval","year":"2006","journal-title":"Parasitology"},{"key":"ref_88","unstructured":"(2018, September 14). Field Evaluations of the Point-of-Care (POC) Circulating Cathodic Antigen (CCA) Urine Assay for Detection of S. mansoni infection. Available online: https:\/\/score.uga.edu\/projects\/poc-cca\/."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Sissoko, M.S., Dabo, A., Traore, H., Diallo, M., Traore, B., Konate, D., Niare, B., Diakite, M., Kamate, B., and Traore, A. (2009). Efficacy of artesunate + sulfamethoxypyrazine\/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0006732"},{"key":"ref_90","unstructured":"(2018, September 14). Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine\/Pyrimethamine for Treating Schistosomiasis, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00510159?term=Co-Arinate&cond=schistosomiasis&rank=1."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Eissa, M.M., El-Moslemany, R.M., Ramadan, A.A., Amer, E.I., El-Azzouni, M.Z., and El-Khordagui, L.K. (2015). Miltefosine Lipid Nanocapsules for Single Dose Oral Treatment of Schistosomiasis Mansoni: A Preclinical Study. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141788"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Simeonov, A., Jadhav, A., Sayed, A.A., Wang, Y., Nelson, M.E., Thomas, C.J., Inglese, J., Williams, D.L., and Austin, C.P. (2008). Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascade. PLoS Negl. Trop. Dis., 2.","DOI":"10.1371\/journal.pntd.0000127"},{"key":"ref_93","unstructured":"(2018, September 14). TI Pharma Pediatric Praziquantel Consortium. Available online: https:\/\/www.tipharma.com\/pharmaceutical-research-projects\/neglected-diseases\/pediatric-praziquantel-consortium\/."},{"key":"ref_94","unstructured":"(2018, September 19). The Truly Staggering Cost of Inventing New Drugs. Available online: https:\/\/www.forbes.com\/sites\/matthewherper\/2012\/02\/22\/the-truly-staggering-cost-of-inventing-new-drugs-the-print-version\/#6a1435725f81."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1016\/S2214-109X(13)70078-0","article-title":"The drug and vaccine landscape for neglected diseases (2000\u20132011): A systematic assessment","volume":"1","author":"Pedrique","year":"2013","journal-title":"Lancet Glob. Health"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2001-1326-2-2","article-title":"Public-private partnerships as driving forces in the quest for innovative medicines","volume":"2","author":"Goldman","year":"2013","journal-title":"Clin. Transl. Med."},{"key":"ref_97","unstructured":"(2018, September 14). Pediatric Praziquantel Consortium. Available online: https:\/\/www.pediatricpraziquantelconsortium.org\/."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/536388a","article-title":"Big Pharma\u2019s Cost Cutting Challenger","volume":"536","author":"Maxmen","year":"2016","journal-title":"Nature"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"591","DOI":"10.4155\/ppa.13.49","article-title":"WIPO Re:Search: A consortium catalyzing research and product development for neglected tropical diseases","volume":"2","author":"Dent","year":"2013","journal-title":"Pharm. Patent Anal."},{"key":"ref_100","unstructured":"(2018, September 18). WIPO Re:Search Guiding Principles. Available online: http:\/\/www.wipo.int\/export\/sites\/www\/research\/docs\/guiding_principles.pdf."},{"key":"ref_101","unstructured":"(2018, September 18). Economic Analysis and Policy Division, United Nations. Available online: https:\/\/www.un.org\/development\/desa\/dpad\/least-developed-country-category.html."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jacbts.2016.03.002","article-title":"Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs","volume":"1","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Rojo-Arreola, L., Long, T., Asarnow, D., Suzuki, B.M., Singh, R., and Caffrey, C.R. (2014). Chemical and genetic validation of the statin drug target to treat the helminth disease, schistosomiasis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0087594"},{"key":"ref_104","first-page":"477","article-title":"Antischistosomal action of mevinolin: Evidence that 3-hydroxy-methylglutaryl-coenzyme a reductase activity in Schistosoma mansoni is vital for parasite survival","volume":"324","author":"Chen","year":"1990","journal-title":"N-S Arch. Pharmacol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1590\/0074-0276108052013011","article-title":"Antischistosomal activity of a calcium channel antagonist on schistosomula and adult Schistosoma mansoni worms","volume":"108","author":"Couto","year":"2013","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1590\/S0001-37652011000200022","article-title":"Schistosoma mansoni Polo-like kinases and their function in control of mitosis and parasite reproduction","volume":"83","author":"Dissous","year":"2011","journal-title":"An. Acad. Brasil. Cienc."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/1386207317666140109120515","article-title":"Nature Bank and the Queensland Compound Library: Unique international resources at the Eskitis Institute for Drug Discovery","volume":"17","author":"Camp","year":"2014","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9431467","article-title":"Effect of Phenotypic Screening of Extracts and Fractions of Erythrophleum ivorense Leaf and Stem Bark on Immature and Adult Stages of Schistosoma mansoni","volume":"2018","author":"Agyare","year":"2018","journal-title":"J. Parasitol. Res."}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/4\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:24:34Z","timestamp":1760185474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/4\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["tropicalmed4010011"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed4010011","relation":{},"ISSN":["2414-6366"],"issn-type":[{"value":"2414-6366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]}}}